Successful treatment of chronic disseminated candidiasis with fluconazole and a granulocyte-macrophage colony-stimulating factor combination

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 10, 2001, Pages 784-786

  Rokusz L ^a   Liptay, L ^a   Kadar K ^a  

^a Infectious Disease Unit   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CYTARABINE; FLUCONAZOLE; IMIPENEM; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VANCOMYCIN;

ACUTE LEUKEMIA; ADULT; ARTICLE; CANDIDIASIS; CASE REPORT; CHILDBIRTH; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; LABORATORY TEST; LEUKEMIA REMISSION; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LIVER DISEASES; SPLENIC DISEASES;

EID: 0034757968     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655401317074671     Document Type: Article

References (14)

1. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia
2. Fungal infections in cancer patients: An international autopsy survey
3. Hepatosplenic candidiasis in patients with acute leukemia: Incidence and prognostic implications
4. Candida species
5. Liver
6. Hepatosplenic candidiasis: Successful treatment with fluconazole
7. Fluconazole in the treatment of hepatosplenic candidiasis
8. Management of invasive candidial infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature
9. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior Amphotericin B therapy
10. Amphotericin B versus Amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients
11. Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection
12. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
13. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer
14. Interferon γ and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia